NTLA Next Earnings Date Notes

— Intellia Therapeutics (NASDAQ: NTLA) is a leading biotechnology company focused on developing transformative, CRISPR/Cas9-based gene editing therapies for serious diseases with unmet medical needs. Using pioneering in vivo and ex vivo gene editing platforms, Intellia aims to develop curative treatments for both genetically defined and broad-based indications, including rare diseases and cancer. As you prepare for the next NTLA earnings call, key metrics to monitor include R&D pipeline progression—specifically clinical trial updates and milestones for therapies like NTLA-2001 (for ATTR amyloidosis) and NTLA-2002 (for hereditary angioedema). Other important metrics are collaboration revenues (notably those from major partnerships such as with Regeneron), cash runway (i.e., cash, cash equivalents & marketable securities relative to R&D spend), and clinical/regulatory milestones announced. Also, pay attention to guidance on trial enrollments, data readouts, and regulatory interactions, as these are critical for long-term value creation. Listening for commentary on technology platforms, competitive landscape, and the company’s ability to scale manufacturing capabilities will provide further insight into NTLA’s potential for sustainable growth in the emerging field of gene editing. The next projected earnings date for NTLA is 11/5/2026 7:00 am (stay tuned for a confirmed earnings date once announced).

NTLA Next Earnings Date FAQ

On this page we presented the NTLA Next Earnings Date information for Intellia Therapeutics along with recent past earnings dates. For Q2 of 2026, NTLA reported earnings of -0.800/share, with the earnings report taking place on 8/6/2026. For Q1 of 2026, NTLA reported earnings of -0.810/share, with the earnings report taking place on 5/11/2026. For Q4 of 2025, NTLA reported earnings of -0.830/share, with the earnings report taking place on 2/26/2026. For Q3 of 2025, NTLA reported earnings of -0.920/share, with the earnings report taking place on 11/6/2025. For Q2 of 2025, NTLA reported earnings of -0.980/share, with the earnings report taking place on 8/7/2025. Based on these past earnings dates, the projected next earnings date for NTLA is 11/5/2026 7:00 am.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Intellia Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Intellia Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Intellia Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next NTLA earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up NTLA's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the NTLA next earnings date.